BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 33749155)

  • 1. Timing of HIV testing among pregnant and breastfeeding women and risk of mother-to-child HIV transmission in Malawi: a sampling-based cohort study.
    Chagomerana MB; Edwards JK; Zalla LC; Carbone NB; Banda GT; Mofolo IA; Hosseinipour MC; Herce ME
    J Int AIDS Soc; 2021 Mar; 24(3):e25687. PubMed ID: 33749155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Community-facility linkage models and maternal and infant health outcomes in Malawi's PMTCT/ART program: A cohort study.
    Herce ME; Chagomerana MB; Zalla LC; Carbone NB; Chi BH; Eliya MT; Phiri S; Topp SM; Kim MH; Wroe EB; Chilangwa C; Chinkonde J; Mofolo IA; Hosseinipour MC; Edwards JK
    PLoS Med; 2021 Sep; 18(9):e1003780. PubMed ID: 34534213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low detectable postpartum viral load is associated with HIV transmission in Malawi's prevention of mother-to-child transmission programme.
    Landes M; van Lettow M; Nkhoma E; Tippett Barr B; Truwah Z; Shouten E; Jahn A; Auld A; Kalua T; van Oosterhout JJ
    J Int AIDS Soc; 2019 Jun; 22(6):e25290. PubMed ID: 31180186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National estimates and risk factors associated with early mother-to-child transmission of HIV after implementation of option B+: a cross-sectional analysis.
    Tippett Barr BA; van Lettow M; van Oosterhout JJ; Landes M; Shiraishi RW; Amene E; Schouten E; Wadonda-Kabondo N; Gupta S; Auld AF; Kalua T; Jahn A
    Lancet HIV; 2018 Dec; 5(12):e688-e695. PubMed ID: 30467022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The National Evaluation of Malawi's PMTCT Program (NEMAPP) study: 24-month HIV-exposed infant outcomes from a prospective cohort study.
    van Lettow M; Tippett Barr BA; van Oosterhout JJ; Schouten E; Jahn A; Kalua T; Auld A; Nyirenda R; Wadonda N; Kim E; Landes M
    HIV Med; 2022 Jul; 23(6):573-584. PubMed ID: 34970836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of maternal ART on mother-to-child transmission (MTCT) of HIV at six weeks postpartum in Rwanda.
    Mugwaneza P; Lyambabaje A; Umubyeyi A; Humuza J; Tsague L; Mwanyumba F; Mutabazi V; Nsanzimana S; Ribakare M; Irakoze A; Mutaganzwa E; Lombard C; Jackson D
    BMC Public Health; 2018 Nov; 18(1):1248. PubMed ID: 30419870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prompt HIV diagnosis and antiretroviral treatment in postpartum women is crucial for prevention of mother to child transmission during breastfeeding: Survey results in a high HIV prevalence community in southern Mozambique after the implementation of Option B.
    Fernández-Luis S; Fuente-Soro L; Nhampossa T; Lopez-Varela E; Augusto O; Nhacolo A; Vazquez O; Saura-Lázaro A; Guambe H; Tibana K; Ngeno B; Juga AJC; Cowan JG; Urso M; Naniche D
    PLoS One; 2022; 17(8):e0269835. PubMed ID: 35917332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National-level effectiveness of ART to prevent early mother to child transmission of HIV in Namibia.
    Agabu A; Baughman AL; Fischer-Walker C; de Klerk M; Mutenda N; Rusberg F; Diergaardt D; Pentikainen N; Sawadogo S; Agolory S; Dinh TH
    PLoS One; 2020; 15(11):e0233341. PubMed ID: 33170840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards elimination of mother-to-child transmission of HIV: performance of different models of care for initiating lifelong antiretroviral therapy for pregnant women in Malawi (Option B+).
    van Lettow M; Bedell R; Mayuni I; Mateyu G; Landes M; Chan AK; van Schoor V; Beyene T; Harries AD; Chu S; Mganga A; van Oosterhout JJ
    J Int AIDS Soc; 2014; 17(1):18994. PubMed ID: 25079437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Timing of Antiretroviral Treatment and Birth Weight on Mother-to-Child Human Immunodeficiency Virus Transmission: Findings From an 18-Month Prospective Cohort of a Nationally Representative Sample of Mother-Infant Pairs During the Transition From Option A to Option B+ in Zimbabwe.
    Dinh TH; Mushavi A; Shiraishi RW; Tippett Barr B; Balachandra S; Shambira G; Nyakura J; Zinyowera S; Tshimanga M; Mugurungi O; Kilmarx PH
    Clin Infect Dis; 2018 Feb; 66(4):576-585. PubMed ID: 29401270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV transmission and retention in care among HIV-exposed children enrolled in Malawi's prevention of mother-to-child transmission programme.
    Haas AD; van Oosterhout JJ; Tenthani L; Jahn A; Zwahlen M; Msukwa MT; Davies MA; Tal K; Phiri N; Spoerri A; Chimbwandira F; Egger M; Keiser O
    J Int AIDS Soc; 2017 Sep; 20(1):21947. PubMed ID: 28884524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term virological outcomes in women who started option B+ care during pregnancy for prevention of mother-to-child transmission of HIV in Dar es Salaam, Tanzania: a cohort study.
    Lyatuu GW; Mwashemele SZ; Urrio R; Naburi H; Kashmir N; Machumi L; Kibao A; Sellah Z; Ulenga N; Orsini N; Biberfeld G; Kilewo C; Ekström AM
    Lancet HIV; 2021 May; 8(5):e256-e265. PubMed ID: 33581776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and outcomes of women initiating ART during pregnancy versus breastfeeding in Option B+ in Malawi.
    Landes M; Sodhi S; Matengeni A; Meaney C; van Lettow M; Chan AK; van Oosterhout JJ
    BMC Public Health; 2016 Aug; 15():713. PubMed ID: 27487775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population-level risk factors for vertical transmission of HIV in the national prevention of mother-to-child transmission programme in South Africa: An ecological analysis.
    Moyo F; Haeri Mazanderani A; Sherman GG; Kufa T
    S Afr Med J; 2022 Mar; 112(3):219-226. PubMed ID: 35380525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the impact of prevention of mother-to-child transmission of HIV in Malawi through immunization clinic-based surveillance.
    Sinunu MA; Schouten EJ; Wadonda-Kabondo N; Kajawo E; Eliya M; Moyo K; Chimbwandira F; Strunin L; Kellerman SE
    PLoS One; 2014; 9(6):e100741. PubMed ID: 24968298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population-level effectiveness of PMTCT Option A on early mother-to-child (MTCT) transmission of HIV in South Africa: implications for eliminating MTCT.
    Goga AE; Dinh TH; Jackson DJ; Lombard CJ; Puren A; Sherman G; Ramokolo V; Woldesenbet S; Doherty T; Noveve N; Magasana V; Singh Y; Ramraj T; Bhardwaj S; Pillay Y;
    J Glob Health; 2016 Dec; 6(2):020405. PubMed ID: 27698999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adolescent and young pregnant women at increased risk of mother-to-child transmission of HIV and poorer maternal and infant health outcomes: A cohort study at public facilities in the Nelson Mandela Bay Metropolitan district, Eastern Cape, South Africa.
    Fatti G; Shaikh N; Eley B; Jackson D; Grimwood A
    S Afr Med J; 2014 Dec; 104(12):874-80. PubMed ID: 26042271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward elimination of mother-to-child transmission of HIV in Malawi: Findings from the Malawi Population-based HIV Impact Assessment (2015-2016).
    Kim E; Jonnalagadda S; Cuervo-Rojas J; Jahn A; Payne D; West C; Ogollah F; Maida A; Kayira D; Nyirenda R; Dobbs T; Patel H; Radin E; Voetsch A; Auld A
    PLoS One; 2022; 17(9):e0273639. PubMed ID: 36048781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral Suppression and HIV Drug Resistance at 6 Months Among Women in Malawi's Option B+ Program: Results From the PURE Malawi Study.
    Hosseinipour M; Nelson JAE; Trapence C; Rutstein SE; Kasende F; Kayoyo V; Kaunda-Khangamwa B; Compliment K; Stanley C; Cataldo F; van Lettow M; Rosenberg NE; Tweya H; Gugsa S; Sampathkumar V; Schouten E; Eliya M; Chimbwandira F; Chiwaula L; Kapito-Tembo A; Phiri S;
    J Acquir Immune Defic Syndr; 2017 Jun; 75 Suppl 2(Suppl 2):S149-S155. PubMed ID: 28498184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.